Although this study demonstrates that haptoglobin is a major contributor to the worsening pathophysiology of SCD, it has limitations, including a relatively small sample size, which limited the ability to draw more conclusive results regarding the influence of the haptoglobin 2 phenotype on oxidative stress dysregulation in patients with SCD. This evidence concerns the gene HP and Schnyder corneal dystrophy.